The CD8+ T cell selectivity of AB248 is essential for optimal anti-tumor activity and safety in nonclinical models

AB248 - Asher Biotherap

https://jitc.bmj.com/content/10/Suppl_2/A1133

Kelly Moynihan 1; Danielle Pappas 1; Hussein Sultan 2; Terrence Park 1; Manu Kumar 1; Ruth Lan 1; Irene Ni 1; Jessie Chen 1; Michael Chin 1; Ton Schumacher 3; Andy Yeung 1; Robert Schreiber 2; Ivana Djuretic 1

Oct 6, 2022